MYRIAD GENETICS, INC.

MYGN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $1.15B

Liabilities Breakdown FY2023

Total Liabilities: $363.3M